Monopar Therapeutics Inc (NASDAQ: MNPR) closed the day trading at $0.99 up 10.51% from the previous closing price of $0.90. In other words, the price has increased by $+0.0942 from its previous closing price. On the day, 899911 shares were traded.
Ratios:
For a better understanding of MNPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.32 and its Current Ratio is at 4.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on January 28, 2021, initiated with a Buy rating and assigned the stock a target price of $49.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNPR now has a Market Capitalization of 13.37M and an Enterprise Value of 4.88M.
Stock Price History:
Over the past 52 weeks, MNPR has reached a high of $3.11, while it has fallen to a 52-week low of $0.27. The 50-Day Moving Average of the stock is 0.4873, while the 200-Day Moving Average is calculated to be 0.5992.
Shares Statistics:
Over the past 3-months, MNPR traded about 5.55M shares per day on average, while over the past 10 days, MNPR traded about 32.98M shares per day. A total of 12.95M shares are outstanding, with a floating share count of 6.37M. Insiders hold about 57.12% of the company’s shares, while institutions hold 1.64% stake in the company. Shares short for MNPR as of Feb 15, 2024 were 62.84k with a Short Ratio of 0.01, compared to 91.88k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.42% and a Short% of Float of 0.98%.
Earnings Estimates
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.16, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.64 and -$0.67 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.58, with 2 analysts recommending between -$0.58 and -$0.59.
